Appetite-regulating peptides, such as leptin, are linked to craving and have been in the focus of alcohol dependence research for years. The objective of our study was to investigate the dynamics of leptin gene promoter methylation during alcohol withdrawal and specific treatment in a rodent (rat) model for alcohol dependence. DNA methylation was measured using direct bisulfite sequencing at 0 h, 24 h, and 6 days of alcohol withdrawal as well as after treatment with alpha-melanocyte-stimulating hormone (alpha-MSH), Beta-Endorphin, or saline. We found significantly lower methylation levels in alcohol-consuming animals compared to alcohol-naïve animals. During 6 days of alcohol deprivation, this difference in methylation vanished. Leptin methylation of the alpha-MSH-treated group and 6 days alcohol-deprived animals was significantly higher than that in saline-treated animals, possibly indicating compensatory effects of the treatment. Our results further expand on previous findings from human studies that explain leptin’s role in bridging the gap between alcohol consumption and appetite regulation.

Keywords:
Leptin, Lipolysis, DNA-methylation, Bisulfite sequencing, Rodent model, Alcohol dependence
1.
World Health Organization: Global status report on alcohol and health 2014 (ed). Geneva, World Health Organization, 2014.
2.
Hillemacher T, Bleich S, Frieling H, Schanze A, Wilhelm J, Sperling W, et al: Evidence of an association of leptin serum levels and craving in alcohol dependence. Psychoneuroendocrinology 2007; 32: 87–90.
3.
Addolorato G, Leggio L, Hillemacher T, Kraus T, Jerlhag E, Bleich S: Hormones and drinking behaviour: new findings on ghrelin, insulin, leptin and volume-regulating hormones. An ESBRA Symposium report. Drug Alcohol Rev 2009; 28: 160–165.
4.
Landgren S, Engel JA, Hyytia P, Zetterberg H, Blennow K, Jerlhag E: Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference. Behav Brain Res 2011; 221: 182–188.
5.
Landgren S, Simms JA, Hyytia P, Engel JA, Bartlett SE, Jerlhag E: Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. Addict Biol 2012; 17: 86–94.
6.
Wilkinson M, Brown R, Imran SA, Ur E: Adipokine gene expression in brain and pituitary gland. Neuroendocrinology 2007; 86: 191–209.
7.
Cheung CC, Clifton DK, Steiner RA: Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997; 138: 4489–4492.
8.
Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, et al: Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001; 411: 480–484.
9.
Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, et al: Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997; 46: 2119–2123.
10.
Muschler MA, Hillemacher T, Kraus C, Kornhuber J, Bleich S, Frieling H: DNA methylation of the POMC gene promoter is associated with craving in alcohol dependence. J Neural Transm (Vienna) 2010; 117: 513–519.
11.
Orellana JA, Cerpa W, Carvajal MF, Lerma-Cabrera JM, Karahanian E, Osorio-Fuentealba C, et al: New implications for the melanocortin system in alcohol drinking behavior in adolescents: the glial dysfunction hypothesis. Front Cell Neurosci 2017; 11: 90.
12.
Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS: Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997; 138: 3859–3863.
13.
Roubos EW, Dahmen M, Kozicz T, Xu L: Leptin and the hypothalamo-pituitary-adrenal stress axis. Gen Comp Endocrinol 2012; 177: 28–36.
14.
Olive MF, Mehmert KK, Koenig HN, Camarini R, Kim JA, Nannini MA, et al: A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice. Psychopharmacology (Berl) 2003; 165: 181–187.
15.
Kiefer F, Jahn H, Schick M, Wiedemann K: Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship. Psychopharmacology (Berl) 2002; 164: 239–240.
16.
Nicolas JM, Fernandez-Sola J, Fatjo F, Casamitjana R, Bataller R, Sacanella E, et al: Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res 2001; 25: 83–88.
17.
Wurst FM, Bechtel G, Forster S, Wolfersdorf M, Huber P, Scholer A, et al: Leptin levels of alcohol abstainers and detoxification patients are not different. Alcohol Alcohol 2003; 38: 364–368.
18.
Bleich S, Lenz B, Ziegenbein M, Beutler S, Frieling H, Kornhuber J, et al: Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol Clin Exp Res 2006; 30: 587–591.
19.
Glahn A, Riera Knorrenschild R, Rhein M, Haschemi Nassab M, Groschl M, Heberlein A, et al: Alcohol-induced changes in methylation status of individual CpG sites, and serum levels of vasopressin and atrial natriuretic peptide in alcohol-dependent patients during detoxification treatment. Eur Addict Res 2014; 20: 143–150.
20.
Hillemacher T, Frieling H, Luber K, Yazici A, Muschler MA, Lenz B, et al: Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal. Psychoneuroendocrinology 2009; 34: 555–560.
21.
Melzner I, Scott V, Dorsch K, Fischer P, Wabitsch M, Bruderlein S, et al: Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter. J Biol Chem 2002; 277: 45420–45427.
22.
Hillemacher T, Weinland C, Lenz B, Kraus T, Heberlein A, Glahn A, et al: DNA methylation of the LEP gene is associated with craving during alcohol withdrawal. Psychoneuroendocrinology 2015; 51: 371–377.
23.
Spanagel R, Holter SM: Long-term alcohol self-administration with repeated alcohol deprivation phases: an animal model of alcoholism? Alcohol Alcohol 1999; 34: 231–243.
24.
Holter SM, Linthorst AC, Reul JM, Spanagel R: Withdrawal symptoms in a long-term model of voluntary alcohol drinking in Wistar rats. Pharmacol Biochem Behav 2000; 66: 143–151.
25.
Lewin J, Schmitt AO, Adorjan P, Hildmann T, Piepenbrock C: Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 2004; 20: 3005–3012.
26.
Kang L, Nagy LE: Chronic ethanol feeding suppresses beta-adrenergic receptor-stimulated lipolysis in adipocytes isolated from epididymal fat. Endocrinology 2006; 147: 4330–4338.
27.
Pownall HJ: Dietary ethanol is associated with reduced lipolysis of intestinally derived lipoproteins. J Lipid Res 1994; 35: 2105–2113.
28.
Schott MB, Rasineni K, Weller SG, Schulze RJ, Sletten AC, Casey CA, et al: β-Adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure. J Biol Chem 2017; 292: 11815–11828.
29.
Siler SQ, Neese RA, Hellerstein MK: De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. Am J Clin Nutr 1999; 70: 928–936.
30.
Szkudelski T, Bialik I, Szkudelska K: Adipocyte lipolysis, hormonal and metabolic changes in ethanol-drinking rats. J Anim Physiol Anim Nutr (Berl) 2004; 88: 251–258.
31.
Hoggard N, Hunter L, Duncan JS, Rayner DV: Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system. J Mol Endocrinol 2004; 32: 145–153.
32.
Richter WO, Naude RJ, Oelofsen W, Schwandt P: In vitro lipolytic activity of beta-endorphin and its partial sequences. Endocrinology 1987; 120: 1472–1476.
33.
Vettor R, Pagano C, Fabris R, Lombardi AM, Macor C, Federspil G: Lipolytic effect of beta-endorphin in human fat cells. Life Sci 1993; 52: 657–661.
34.
Wellhoner P, Horster R, Jacobs F, Sayk F, Lehnert H, Dodt C: Intranasal application of the melanocortin 4 receptor agonist MSH/ACTH(4–10) in humans causes lipolysis in white adipose tissue. Int J Obes (Lond) 2012; 36: 703–708.
35.
Farrell M, Howes S, Bebbington P, Brugha T, Jenkins R, Lewis G, et al: Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 2001; 179: 432–437.
36.
Dogan MV, Lei MK, Beach SR, Brody GH, Philibert RA: Alcohol and tobacco consumption alter hypothalamic pituitary adrenal axis DNA methylation. Psychoneuroendocrinology 2016; 66: 176–184.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.